Schedule 13G ownership disclosure

X4 PHARMACEUTICALS INC

Security class unavailable · CUSIP: 98420X103

Event date: 2022-01-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,810,087
Percent of class
6.4400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-005234
Form type
SC 13G
Filer
Lincoln Park Capital Fund, LLC
CIK
CIK 1592644
Filed
Jan 19, 2022
Reporting period
Jan 14, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub